Condition

Lymphoma, Non Hodgkin (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

Genentech, Inc. (1)

Collaborator

Intervention

cyclophosphamide (1)

doxorubicin (1)

obinutuzumab (1)

polatuzumab vedotin (1)

prednisolone (1)

prednisone (1)

rituximab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

lymphoma, non hodgkin

Showing NaN - NaN of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Lymphoma, Non Hodgkin Trial in France, United States (Cyclophosphamide, Doxorubicin, Obinutuzumab)

Completed

Lymphoma, Non Hodgkin

Cyclophosphamide
+6 more

Birmingham, Alabama
+10 more

Feb 18, 2020